SR

Solanki Ramesh

Active Director Director DIN 10568569
DIN 10568569 First appointment Mar 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Solanki Ramesh

Data last updated:

Solanki Ramesh is a Director at Solange Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals. Solange Pharmaceuticals Private Limited reported revenue of ₹28.7 Lakh (FY 2025).

DIN 10568569
Primary Designation Director
Industry Chemicals
First Appointment 29 Mar 2024
Oldest Company Age 11 yrs
Largest company Solange Pharmaceuticals Private Limited · ₹28.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20242015₹28.7 Lakh (FY 2025)Active

Board colleagues of Solanki Ramesh

Directorship timeline

Open interactive timeline →
Solange Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Solanki Ramesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solanki Ramesh

Solanki Ramesh currently holds 1 directorship: Solange Pharmaceuticals Private Limited (Director, since 29 Mar 2024, revenue ₹28.7 Lakh (FY 2025)).

Solanki Ramesh was first appointed on 29 Mar 2024 as Director at Solange Pharmaceuticals Private Limited.

The current boards of Solanki Ramesh's companies include Dhaneshwar Chandulal Solanki (Solange Pharmaceuticals Private Limited), Sheetal Uday Trivedi (Solange Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available